(Q50878939)

24 March 2018

title

Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva. (English)

1 reference

24 March 2018

author name string

Mino A

1

1 reference

24 March 2018

Page D

2

1 reference

24 March 2018

Dumont P

3

1 reference

24 March 2018

Broers B

4

1 reference

24 March 2018

publication date

1 May 1998

1 reference

24 March 2018

Drug and Alcohol Dependence

published in

1 reference

24 March 2018

volume

50

1 reference

24 March 2018

issue

3

1 reference

24 March 2018

page(s)

233-239

1 reference

24 March 2018

Methadone Maintenance Dosage Levels and Program Retention

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Methadone dose and heroin use during maintenance treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Long-term outcome of patients treated with methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Methadone maintenance treatment in opiate dependence: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

The Swedish methadone maintenance program: A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Gender differences among opioid abusers: pathways to disorder and profiles of psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Women in recovery. Their perceptions of treatment effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Heterogeneity of psychiatric diagnosis in treated opiate addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Retention patterns in a therapeutic community for the treatment of drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Comparison of the Effect of High and Low Doses of Methadone on Treatment Outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Treatment for drug abuse. Follow-up outcomes and length of time spent.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Psychosocial correlates of retention in methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Women and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Dose-response effects of methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

Retention in a low-threshold methadone maintenance program

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900035-0

7 January 2021

10.1016/S0376-8716(98)00035-0

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

9649977

1 reference

24 March 2018